Stockreport

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets

Pyxis Oncology, Inc.  (PYXS) 
PDF BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for diffi [Read more]